ID

40484

Beschrijving

Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting; ODM derived from: https://clinicaltrials.gov/show/NCT01175330

Link

https://clinicaltrials.gov/show/NCT01175330

Trefwoorden

Versies (1)
  1. 25-04-20 25-04-20 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

25 april 2020

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Ischemic Heart Disease NCT01175330

Engels

Eligibility Ischemic Heart Disease NCT01175330

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
elective cabg surgery.
Beschrijving

Coronary Artery Bypass Surgery elective

Datatype

boolean

Alias
UMLS CUI [1,1]
C0010055
UMLS CUI [1,2]
C0439608
signed, documented informed consent prior to admission to the study.
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
unstable angina, requiring intervention or cabg <24 hrs after screening.
Beschrijving

Unstable Angina Requirement Intervention | Unstable Angina Requirement CABG

Datatype

boolean

Alias
UMLS CUI [1,1]
C0002965
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0184661
UMLS CUI [2,1]
C0002965
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0010055
decompensated congestive heart failure.
Beschrijving

CONGESTIVE HEART FAILURE DECOMPENSATED

Datatype

boolean

Alias
UMLS CUI [1]
C0742746
chronic, persistent, paroxysmal atrial fibrillation.
Beschrijving

Chronic atrial fibrillation | Persistent atrial fibrillation | Paroxysmal atrial fibrillation

Datatype

boolean

Alias
UMLS CUI [1]
C0694539
UMLS CUI [2]
C2585653
UMLS CUI [3]
C0235480
uncorrected significant valvular heart disease
Beschrijving

Heart valve disease uncorrected

Datatype

boolean

Alias
UMLS CUI [1,1]
C0018824
UMLS CUI [1,2]
C4072785
known hypersensitivity to the study drug
Beschrijving

Hypersensitivity Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
left ventricular dysfunction (ejection fraction <35%)
Beschrijving

Ventricular Dysfunction, Left | Cardiac ejection fraction

Datatype

boolean

Alias
UMLS CUI [1]
C0242698
UMLS CUI [2]
C0232174
use of anti-arrhythmic drugs other than beta blockers
Beschrijving

Anti-Arrhythmia Agents | Exception Adrenergic beta-1 Receptor Antagonists

Datatype

boolean

Alias
UMLS CUI [1]
C0003195
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0304516
non-cardiac illness with a life expectancy of less than 1 year
Beschrijving

Illness Except Heart Diseases | Life Expectancy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0332300
UMLS CUI [1,3]
C0018799
UMLS CUI [2]
C0023671
bleeding diathesis or history of coagulopathy
Beschrijving

Bleeding tendency | Blood Coagulation Disorder

Datatype

boolean

Alias
UMLS CUI [1]
C1458140
UMLS CUI [2]
C0005779
significant renal and liver insufficiency
Beschrijving

Renal Insufficiency | Hepatic Insufficiency

Datatype

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C1306571
significant thyroid, pulmonary disease
Beschrijving

Thyroid Disease | Lung disease

Datatype

boolean

Alias
UMLS CUI [1]
C0040128
UMLS CUI [2]
C0024115
uncontrolled diabetes mellitus
Beschrijving

Diabetic - poor control

Datatype

boolean

Alias
UMLS CUI [1]
C0421258
patients on anti-arrhythmic drugs
Beschrijving

Anti-Arrhythmia Agents

Datatype

boolean

Alias
UMLS CUI [1]
C0003195
patients with pacemaker
Beschrijving

Artificial cardiac pacemaker

Datatype

boolean

Alias
UMLS CUI [1]
C0030163
patients unable to provide/sign informed consent.
Beschrijving

Informed Consent Unable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
patients currently taking marine based omega-three fish oil supplements.
Beschrijving

Omega-3 Fatty Acid Fish Oil Supplements

Datatype

boolean

Alias
UMLS CUI [1,1]
C0015689
UMLS CUI [1,2]
C0016157
UMLS CUI [1,3]
C0242295
disturbances in lipid metabolism, serum triglyceride value >3 mmol/l
Beschrijving

Lipid Metabolism Disorders | Serum Triglyceride Measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0154251
UMLS CUI [2]
C0542495
Terug naar het begin van de pagina

Similar models

Eligibility Ischemic Heart Disease NCT01175330

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Coronary Artery Bypass Surgery elective
Item
elective cabg surgery.
boolean
C0010055 (UMLS CUI [1,1])
C0439608 (UMLS CUI [1,2])
Informed Consent
Item
signed, documented informed consent prior to admission to the study.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Unstable Angina Requirement Intervention | Unstable Angina Requirement CABG
Item
unstable angina, requiring intervention or cabg <24 hrs after screening.
boolean
C0002965 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0184661 (UMLS CUI [1,3])
C0002965 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0010055 (UMLS CUI [2,3])
CONGESTIVE HEART FAILURE DECOMPENSATED
Item
decompensated congestive heart failure.
boolean
C0742746 (UMLS CUI [1])
Chronic atrial fibrillation | Persistent atrial fibrillation | Paroxysmal atrial fibrillation
Item
chronic, persistent, paroxysmal atrial fibrillation.
boolean
C0694539 (UMLS CUI [1])
C2585653 (UMLS CUI [2])
C0235480 (UMLS CUI [3])
Heart valve disease uncorrected
Item
uncorrected significant valvular heart disease
boolean
C0018824 (UMLS CUI [1,1])
C4072785 (UMLS CUI [1,2])
Hypersensitivity Investigational New Drugs
Item
known hypersensitivity to the study drug
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Ventricular Dysfunction, Left | Cardiac ejection fraction
Item
left ventricular dysfunction (ejection fraction <35%)
boolean
C0242698 (UMLS CUI [1])
C0232174 (UMLS CUI [2])
Anti-Arrhythmia Agents | Exception Adrenergic beta-1 Receptor Antagonists
Item
use of anti-arrhythmic drugs other than beta blockers
boolean
C0003195 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0304516 (UMLS CUI [2,2])
Illness Except Heart Diseases | Life Expectancy
Item
non-cardiac illness with a life expectancy of less than 1 year
boolean
C0221423 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C0018799 (UMLS CUI [1,3])
C0023671 (UMLS CUI [2])
Bleeding tendency | Blood Coagulation Disorder
Item
bleeding diathesis or history of coagulopathy
boolean
C1458140 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
Renal Insufficiency | Hepatic Insufficiency
Item
significant renal and liver insufficiency
boolean
C1565489 (UMLS CUI [1])
C1306571 (UMLS CUI [2])
Thyroid Disease | Lung disease
Item
significant thyroid, pulmonary disease
boolean
C0040128 (UMLS CUI [1])
C0024115 (UMLS CUI [2])
Diabetic - poor control
Item
uncontrolled diabetes mellitus
boolean
C0421258 (UMLS CUI [1])
Anti-Arrhythmia Agents
Item
patients on anti-arrhythmic drugs
boolean
C0003195 (UMLS CUI [1])
Artificial cardiac pacemaker
Item
patients with pacemaker
boolean
C0030163 (UMLS CUI [1])
Informed Consent Unable
Item
patients unable to provide/sign informed consent.
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Omega-3 Fatty Acid Fish Oil Supplements
Item
patients currently taking marine based omega-three fish oil supplements.
boolean
C0015689 (UMLS CUI [1,1])
C0016157 (UMLS CUI [1,2])
C0242295 (UMLS CUI [1,3])
Lipid Metabolism Disorders | Serum Triglyceride Measurement
Item
disturbances in lipid metabolism, serum triglyceride value >3 mmol/l
boolean
C0154251 (UMLS CUI [1])
C0542495 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial